Profile
Bernard Mach is the founder of NovImmune SA, founded in 1998, and MaxiVAX SA, founded in 2005 where he holds the title of Director.
He also held the position of Deputy Chairman at Lonza Group AG and was a Director at Serono SA from 1997 to 2007.
Additionally, he was a Professor at the University of Geneva.
Dr. Mach is also the founder of LO FUNDS LIFE SCIENCES EXPERTISE, Biogen MA, Inc. He holds a doctorate degree from The Rockefeller University and the University of Geneva.
Bernard Mach active positions
| Companies | Position | Start |
|---|---|---|
Release Therapeutics SA
Release Therapeutics SA BiotechnologyHealth Technology Develops first cell microencapsulation technology to deliver therapeutic proteins beyond the human blood-brain barrier | Founder | 2004-12-31 |
Former positions of Bernard Mach
| Companies | Position | End |
|---|---|---|
LO FUNDS LIFE SCIENCES EXPERTISE
LO FUNDS LIFE SCIENCES EXPERTISE Investment Trusts/Mutual FundsMiscellaneous Open-End Investment Fund/Unit Trust | Founder | 2014-03-27 |
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Specializes in the manufacture of cancer and cardiovascular drugs | Director/Board Member | 2007-01-16 |
University of Geneva
University of Geneva Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 1997-12-31 |
| NOVIMMUNE SA | Founder | - |
| LONZA GROUP AG | Director/Board Member | - |
Training of Bernard Mach
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Develops and manufactures drugs related to immunology, neurobiology and oncology | Health Technology |
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Specializes in the manufacture of cancer and cardiovascular drugs | Health Technology |
Lonza Group AG
Lonza Group AG BiotechnologyHealth Technology Develops and manufactures, biologics, biopharmaceuticals, small molecules & health ingredients | Health Technology |
LO FUNDS LIFE SCIENCES EXPERTISE
LO FUNDS LIFE SCIENCES EXPERTISE Investment Trusts/Mutual FundsMiscellaneous Open-End Investment Fund/Unit Trust | Miscellaneous |
The Rockefeller University
The Rockefeller University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Geneva
University of Geneva Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novimmune SA
Novimmune SA BiotechnologyHealth Technology Operates as a drug discovery and development company | Health Technology |
Release Therapeutics SA
Release Therapeutics SA BiotechnologyHealth Technology Develops first cell microencapsulation technology to deliver therapeutic proteins beyond the human blood-brain barrier | Health Technology |
- Stock Market
- Insiders
- Bernard Mach
















